Tissue Microarrays: Construction and Uses
Tissue microarrays (TMAs) are produced by taking small punches from a series of paraffin-embedded (donor) tissue blocks and transferring these tissue cores into a positionally encoded array in a recipient paraffin block. Though TMAs are not used for clinical diagnosis, they have several advantages over using conventional whole histological sections for research. Tissue from multiple patients or blocks can be examined on the same slide, and only a very small amount of reagent is required to stain or label an entire array. Multiple sections (100–300) can be cut from a single array block, allowing for hundreds of analyses per microarray. These advantages allow the use of TMAs in high-throughput procedures, such as screening antibodies for diagnostics and validating prognostic markers that are impractical using conventional whole tissue sections. TMAs can be used for immunohistochemistry, immunofluorescence, in situ hybridization, and conventional histochemical staining. Finally, several tissue cores may be taken without consuming the tissue block, allowing the donor block to be returned to its archive for any additional studies.
Key wordsFluorescence in situ hybridization Formalin-fixed paraffin-embedded Hematoxylin and eosin HER-2 gene Tissue microarray TMA
- 10.Carlson, R. W., Moench, S. J., Hammond, M. E., Perez, E. A., Burstein, H. J., Allred, D. C., et al. (2006) HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Canc Netw. 4 Suppl 3, S1–22.Google Scholar
- 12.Graham, A. D., Faratian, D., Rae, F., and Thomas, J. S. (2008) Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization. Histopathology 52, 847–55.PubMedCrossRefGoogle Scholar
- 13.Faratian, D., Graham, A., Rae, F., and Thomas, J. (2009) Rapid screening of tissue microarrays for Her-2 fluorescence in situ hybridization testing is an accurate, efficient and economic method of providing an entirely in situ hybridization-based Her-2 testing service. Histopathology 54, 428–32.PubMedCrossRefGoogle Scholar
- 16.Allen, T. C. (1992) Hematoxylin and Eosin. In E. B. Prophet, B. Mills, J. B. Arrington, and L. H. Sobin, ed. AIFP Laboratory Methods in Histotechnology, Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC, 53–58.Google Scholar